Eric Gross

Title: Innovations by Eric Gross in Medical Treatments

Introduction

Eric Gross is an accomplished inventor based in Menlo Park, California. He has made significant contributions to the field of medical treatments, particularly in addressing conditions such as endometriosis. With a total of two patents to his name, Gross has demonstrated a commitment to advancing healthcare through innovative solutions.

Latest Patents

Eric Gross's latest patents include groundbreaking methods and compositions for treating endometriosis and its associated symptoms. These methods involve administering an agent that promotes ALDH activity to alleviate pain related to endometriosis. Additionally, he has developed peptide modulators that influence specific calcineurin protein-protein interactions. These methods include contacting a cell with a peptidic agent that modulates the interaction between calcineurin and a TRPV channel. His work also encompasses pharmaceutical compositions that selectively modulate these interactions, providing new avenues for treatment.

Career Highlights

Gross is affiliated with Leland Stanford Junior University, where he continues to engage in research and development. His work has not only contributed to the scientific community but has also paved the way for potential therapeutic advancements in treating complex medical conditions.

Collaborations

Eric Gross has collaborated with notable colleagues, including Daria D Mochly-Rosen and Stacy Lynn McAllister. These partnerships have further enriched his research and innovation efforts.

Conclusion

Eric Gross's contributions to medical innovation, particularly in the treatment of endometriosis, highlight his role as a leading inventor in the field. His patents reflect a dedication to improving patient outcomes through scientific advancements.